You've got it now. Functionally no different from the authority they've been granted at the last several annual shareholder meetings. They have a range of dates and a range of ratios, and they're not bound to do anything.
I think they've waited on this authorization before proceeding with any interim data analysis. If I were them, I wouldn't want to have the interim data in hand, with a likely imperative to disclose to the market, without having my full toolkit in order. I think we see something on interim data within three weeks now.